Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9760277rdf:typepubmed:Citationlld:pubmed
pubmed-article:9760277lifeskim:mentionsumls-concept:C0003062lld:lifeskim
pubmed-article:9760277lifeskim:mentionsumls-concept:C0440744lld:lifeskim
pubmed-article:9760277lifeskim:mentionsumls-concept:C0242958lld:lifeskim
pubmed-article:9760277lifeskim:mentionsumls-concept:C0184511lld:lifeskim
pubmed-article:9760277lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:9760277lifeskim:mentionsumls-concept:C0008565lld:lifeskim
pubmed-article:9760277lifeskim:mentionsumls-concept:C1980032lld:lifeskim
pubmed-article:9760277pubmed:issue9lld:pubmed
pubmed-article:9760277pubmed:dateCreated1998-11-9lld:pubmed
pubmed-article:9760277pubmed:abstractTextMalondialdehyde (MDA) is a major lipid peroxidation product that is mutagenic and tumorigenic. The MDA-modified DNA adduct, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)pyrimido[1, 2-alpha]purin-10(3H)-one (M1G), has been detected in human tissues and may be a marker of human cancer risk. In this paper, we describe an improved 32P-postlabeling/HPLC method for sensitive detection and quantitation of this MDA-modified 2'-deoxyribonucleotide adduct. Specific improvements include (i) unequivocal structural identification of the postlabeling products, both the 3', 5'-bisphosphate of M1G (MDA-3',5'-dGDP) and the 5'-monophosphate of M1G (MDA-5'-dGMP); (ii) efficient separation of the 32P-postlabeling products by HPLC; and (iii) the incorporation of a synthetically prepared MDA-modified DNA (or the 3'-monophosphate of M1G) with a known modification level as an internal standard. This improved quantitative methodology provides high intra- and inter-assay reproducibility and has been applied to the analysis of this adduct in rodent and human samples.lld:pubmed
pubmed-article:9760277pubmed:languageenglld:pubmed
pubmed-article:9760277pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9760277pubmed:citationSubsetIMlld:pubmed
pubmed-article:9760277pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9760277pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9760277pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9760277pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9760277pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9760277pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9760277pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9760277pubmed:statusMEDLINElld:pubmed
pubmed-article:9760277pubmed:monthSeplld:pubmed
pubmed-article:9760277pubmed:issn0893-228Xlld:pubmed
pubmed-article:9760277pubmed:authorpubmed-author:FuP PPPlld:pubmed
pubmed-article:9760277pubmed:authorpubmed-author:DoergeD RDRlld:pubmed
pubmed-article:9760277pubmed:authorpubmed-author:SudVVlld:pubmed
pubmed-article:9760277pubmed:authorpubmed-author:YiPPlld:pubmed
pubmed-article:9760277pubmed:issnTypePrintlld:pubmed
pubmed-article:9760277pubmed:volume11lld:pubmed
pubmed-article:9760277pubmed:ownerNLMlld:pubmed
pubmed-article:9760277pubmed:authorsCompleteYlld:pubmed
pubmed-article:9760277pubmed:pagination1032-41lld:pubmed
pubmed-article:9760277pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9760277pubmed:meshHeadingpubmed-meshheading:9760277-...lld:pubmed
pubmed-article:9760277pubmed:meshHeadingpubmed-meshheading:9760277-...lld:pubmed
pubmed-article:9760277pubmed:meshHeadingpubmed-meshheading:9760277-...lld:pubmed
pubmed-article:9760277pubmed:meshHeadingpubmed-meshheading:9760277-...lld:pubmed
pubmed-article:9760277pubmed:meshHeadingpubmed-meshheading:9760277-...lld:pubmed
pubmed-article:9760277pubmed:meshHeadingpubmed-meshheading:9760277-...lld:pubmed
pubmed-article:9760277pubmed:meshHeadingpubmed-meshheading:9760277-...lld:pubmed
pubmed-article:9760277pubmed:meshHeadingpubmed-meshheading:9760277-...lld:pubmed
pubmed-article:9760277pubmed:meshHeadingpubmed-meshheading:9760277-...lld:pubmed
pubmed-article:9760277pubmed:meshHeadingpubmed-meshheading:9760277-...lld:pubmed
pubmed-article:9760277pubmed:meshHeadingpubmed-meshheading:9760277-...lld:pubmed
pubmed-article:9760277pubmed:meshHeadingpubmed-meshheading:9760277-...lld:pubmed
pubmed-article:9760277pubmed:meshHeadingpubmed-meshheading:9760277-...lld:pubmed
pubmed-article:9760277pubmed:meshHeadingpubmed-meshheading:9760277-...lld:pubmed
pubmed-article:9760277pubmed:meshHeadingpubmed-meshheading:9760277-...lld:pubmed
pubmed-article:9760277pubmed:meshHeadingpubmed-meshheading:9760277-...lld:pubmed
pubmed-article:9760277pubmed:meshHeadingpubmed-meshheading:9760277-...lld:pubmed
pubmed-article:9760277pubmed:meshHeadingpubmed-meshheading:9760277-...lld:pubmed
pubmed-article:9760277pubmed:meshHeadingpubmed-meshheading:9760277-...lld:pubmed
pubmed-article:9760277pubmed:year1998lld:pubmed
pubmed-article:9760277pubmed:articleTitleAn improved 32P-postlabeling/high-performance liquid chromatography method for the analysis of the malondialdehye-derived 1, N2-propanodeoxyguanosine DNA adduct in animal and human tissues.lld:pubmed
pubmed-article:9760277pubmed:affiliationNational Center for Toxicological Research, Jefferson, Arkansas 72079, USA.lld:pubmed
pubmed-article:9760277pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9760277pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9760277lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9760277lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9760277lld:pubmed